戻る Agenda
Session 3: Biotherapeutic Products and Biosimilars
Session Chair(s)
Susanne Ausborn, PhD
Global Head International Regulatory Policy
Roche, Switzerland
Myriam Sedrati
Regulatory Affairs Director North and West Africa
Merck Sharp & Dohme, Morocco
• Updates from the Region: o Morocco o Algeria o Tunisia • Vaccines Registrations • Biotherapeutic products: Clinical aspects to be addressed
Speaker(s)
WHO Guidelines
Hye-Na Kang, DVM
Access To Medicines and Health Products, World Health Organization, Switzerland
Scientist
Patients’ Perspective on Biosimilars
Kawaldip Sehmi
International Alliance Of Patients' Organizations (IAPO), United Kingdom
CEO
Interchangeability and Extrapolation
Virginia Acha, PhD, MSc
Merck Sharpe & Dohme LLC , United States
AVP, Global Regulatory Policy
• Updates from the Region: Tunisia
Houda Ben Khedija
Ministère de la santé publique, Tunisia
Directeur de l’Inspection Pharmaceutique
Peter J. Pitts
Center for Medicine in the Public Interest (CMPI), United States
President